Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases
Description
                Persistent COVID-19 is a well recognized issue of concern in patients with hematological malignancies. Such patients are not only at risk of mortality due to the infection itself, but are also at risk of suboptimal malignancy-related outcomes because
          